PGGM Investments purchased a new stake in MetLife, Inc. (NYSE:MET – Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 3,667 shares of the financial services provider’s stock, valued at approximately $272,000.
Other hedge funds have also bought and sold shares of the company. Vanguard Group Inc. increased its position in shares of MetLife by 3.4% in the first quarter. Vanguard Group Inc. now owns 59,622,348 shares of the financial services provider’s stock valued at $4,418,612,000 after buying an additional 1,974,268 shares in the last quarter. Norges Bank purchased a new stake in MetLife in the 4th quarter worth $558,460,000. Dimensional Fund Advisors LP raised its position in MetLife by 20.9% during the fourth quarter. Dimensional Fund Advisors LP now owns 4,053,851 shares of the financial services provider’s stock worth $268,090,000 after acquiring an additional 700,788 shares during the period. Charles Schwab Investment Management Inc. lifted its holdings in MetLife by 2.8% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 3,878,238 shares of the financial services provider’s stock valued at $256,468,000 after purchasing an additional 104,116 shares in the last quarter. Finally, Nordea Investment Management AB grew its position in shares of MetLife by 4.1% in the first quarter. Nordea Investment Management AB now owns 2,772,751 shares of the financial services provider’s stock valued at $205,544,000 after purchasing an additional 108,739 shares during the period. Hedge funds and other institutional investors own 89.81% of the company’s stock.
MetLife Trading Down 6.9 %
Shares of MetLife stock opened at $70.56 on Friday. The stock has a 50 day moving average of $71.94 and a 200 day moving average of $71.22. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.16 and a current ratio of 0.16. The firm has a market capitalization of $50.18 billion, a price-to-earnings ratio of 24.25, a PEG ratio of 0.65 and a beta of 1.11. MetLife, Inc. has a fifty-two week low of $57.91 and a fifty-two week high of $79.34.
MetLife announced that its Board of Directors has initiated a share repurchase plan on Wednesday, May 1st that permits the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization permits the financial services provider to buy up to 6% of its shares through open market purchases. Shares repurchase plans are typically an indication that the company’s leadership believes its shares are undervalued.
MetLife Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 10th. Stockholders of record on Tuesday, August 6th will be issued a $0.545 dividend. The ex-dividend date of this dividend is Tuesday, August 6th. This represents a $2.18 annualized dividend and a dividend yield of 3.09%. MetLife’s dividend payout ratio is currently 74.91%.
Analysts Set New Price Targets
Several research firms recently weighed in on MET. Citigroup upped their price target on shares of MetLife from $83.00 to $89.00 and gave the stock a “buy” rating in a research report on Tuesday, July 23rd. JPMorgan Chase & Co. lifted their price target on MetLife from $81.00 to $86.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 2nd. Argus increased their price objective on MetLife from $77.00 to $80.00 and gave the company a “buy” rating in a research note on Wednesday, May 22nd. Keefe, Bruyette & Woods decreased their price objective on MetLife from $86.00 to $85.00 and set an “outperform” rating on the stock in a report on Monday, July 8th. Finally, Bank of America reduced their target price on shares of MetLife from $99.00 to $96.00 and set a “buy” rating for the company in a research report on Thursday. One research analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat, MetLife has a consensus rating of “Moderate Buy” and a consensus target price of $82.14.
Get Our Latest Stock Analysis on MetLife
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
- Five stocks we like better than MetLife
- Energy and Oil Stocks Explained
- Market Crash? No Problem for DoorDash Stock’s Impressive Earnings
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- How to Choose Top Rated Stocks
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.